Zentist announced that Pearl launched Second Opinion 3D, a commercial product for general dentists using its FDA-cleared 3D imaging AI.

Public source

Publisher name

Public post

Pearl has launched Second Opinion 3D, putting its FDA-cleared 3D imaging AI into general dentists' hands as a commercial product for the first time. General practices ar…

Log in to read the full post

Company

About Zentist

Zentist uses advanced technology to simplify and automate insurance revenue cycle management (RCM) for multi-location dental service providers located throughout the United States. Remit AI, the company's flagship cloud-based RCM software, centralizes explanation of benefits (EOBs) and electronic remittance advice (ERA) data from across 1800+ payers for faster payment posting and ease of reconciliation, while reducing insurance denials through better payer-specific data intelligence. At a time when U.S. dental practices and dental support/partnership organizations (DSOs/DPOs) collectively lose an estimated $2.1 billion due to legacy billing systems, Zentist leverages robotic process automation (RPA) and machine learning to place otherwise tedious RCM tasks, such as insurance payment posting, on autopilot, thereby freeing up employee time for elevating the patient experience. Based in San Francisco and having successfully completed Series A funding, Zentist is backed by leading investment firms.

See more

Latest activity

17 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.